Pharmacy

Your Article Summary

See Latest Articles

Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: A look at the clinical and pharmacological evidence
Pharmacology & Therapeutics, 06/24/09

Lordkipanidze M et al. - This review article describes the thrombotic risks associated with discontinuing antiplatelet therapy and the bleeding risks associated with continuing these drugs. By integrating the current understanding of the pharmacology of antiplatelet agents and the kinetics of platelet function recovery, this article unveils the possibility of a pharmacological rebound phenomenon which could lead to adverse ischemic events, and supports the warning against premature discontinuation of antiplatelet drugs issued in current guidelines.

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Use of psychotropic drugs and analgesics among users of antiobesity drugs - a population based study
Pharmacoepidemiology and Drug Safety, 12/16/09

Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09

A Clinical Review of Echinocandins in Pediatric Patients
Annals of Pharmacotherapy, 12/16/09

 See all of Other Drugs

Today in Pharmacokinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

Which drug is effective and safe for acute malaria in pregnancy? Reviewing the evidence
Drug Development Research, 12/16/09

Integrated Software Environment Based on COMKAT for Analyzing Tracer Pharmacokinetics with Molecular Imaging
The Journal of Nuclear Medicine, 12/15/09

Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer
The Journal of Nuclear Medicine, 12/15/09

 See all of Pharmacokinetics